These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3460565)

  • 21. New approaches to hepatitis B vaccines.
    Gerin JL; Purcell RH
    Prog Clin Biol Res; 1983; 143():369-77. PubMed ID: 6230679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Environmental issues in the planned release of genetically-engineered organisms.
    Sarma V
    Aust J Biotechnol; 1989 Jan; 3(1):13-6. PubMed ID: 2485312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the mucosa: genetically engineered vaccines and mucosal immune responses.
    Stevceva L; Abimiku AG; Franchini G
    Genes Immun; 2000 Jun; 1(5):308-15. PubMed ID: 11196691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Viruses and gene engineering].
    Tikhonenko TI
    Vestn Akad Med Nauk SSSR; 1983; (12):67-75. PubMed ID: 6198816
    [No Abstract]   [Full Text] [Related]  

  • 25. Strategies of constructing recombinant vaccines.
    Sałamaszyńska-Guz A; Klimuszko D
    Pol J Vet Sci; 2009; 12(1):133-9. PubMed ID: 19459451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prospects and achievements of genetic engineering in development of antiviral vaccines].
    Tikhonenko TI
    Mol Biol (Mosk); 1984; 18(1):176-88. PubMed ID: 6323971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant DNA technology for the preparation of subunit vaccines.
    Bachrach HL
    J Am Vet Med Assoc; 1982 Nov; 181(10):992-9. PubMed ID: 6129235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poultry coccidiosis: recent advancements in control measures and vaccine development.
    Dalloul RA; Lillehoj HS
    Expert Rev Vaccines; 2006 Feb; 5(1):143-63. PubMed ID: 16451116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of genetic engineering methods to create viral vaccines].
    Tatarov G
    Vet Med Nauki; 1987; 24(1):88-92. PubMed ID: 3303657
    [No Abstract]   [Full Text] [Related]  

  • 30. Control of infectious bursal disease virus by vaccination.
    Saif YM
    Dev Biol (Basel); 2004; 119():143-6. PubMed ID: 15742625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction, expression and immunoassay detection of recombinant plasmid encoding fusion protein of Roman chicken complement C3d and Newcastle disease virus F gene.
    Liu D; Niu ZX
    Scand J Immunol; 2008 Dec; 68(6):598-606. PubMed ID: 19055698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Past and present vaccine development strategies for the control of foot-and-mouth disease.
    Balamurugan V; Kumar RM; Suryanarayana VV
    Acta Virol; 2004; 48(4):201-14. PubMed ID: 15745043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetically engineered dendritic cell-based cancer vaccines (review).
    Bubeník J
    Int J Oncol; 2001 Mar; 18(3):475-8. PubMed ID: 11179474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The safe and effective use of fowlpox virus as a vector for poultry vaccines.
    McMillen JK; Cochran MD; Junker DE; Reddy DN; Valencia DM
    Dev Biol Stand; 1994; 82():137-45. PubMed ID: 7958468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Encephalitis vaccination of pheasants.
    Sussman O
    J Am Vet Med Assoc; 1983 Dec; 183(12):1375. PubMed ID: 6654718
    [No Abstract]   [Full Text] [Related]  

  • 36. Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection.
    Ramshaw IA; Andrew ME; Phillips SM; Boyle DB; Coupar BE
    Nature; 1987 Oct 8-14; 329(6139):545-6. PubMed ID: 3498904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens.
    Rong J; Cheng T; Liu X; Jiang T; Gu H; Zou G
    Vaccine; 2005 Sep; 23(40):4844-51. PubMed ID: 15979770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful control of Marek's disease by vaccination.
    Nair V
    Dev Biol (Basel); 2004; 119():147-54. PubMed ID: 15742626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic engineering and coagulation factors.
    Fass DN; Toole JJ
    Clin Haematol; 1985 Jun; 14(2):547-70. PubMed ID: 3930118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry.
    Skinner MA; Laidlaw SM; Eldaghayes I; Kaiser P; Cottingham MG
    Expert Rev Vaccines; 2005 Feb; 4(1):63-76. PubMed ID: 15757474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.